You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic myelogenous leukemia in chronic phase

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • +3 more
  • Augusta, Georgia
  • +1 more
Jul 14, 2022

Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

Suspended
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Recombinant Interleukin-7
  • Houston, Texas
    M D Anderson Cancer Center
Jan 26, 2023

Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia Trial in Philadelphia (Text

Recruiting
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Chronic Phase Chronic Myelogenous Leukemia
  • Text Message-Based Navigation Intervention
  • Survey Administration
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Apr 7, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +13 more
  • CMVpp65-A*0201 peptide vaccine
  • +2 more
  • Duarte, California
  • +4 more
Jan 4, 2023

"Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

Not yet recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
    • Sohag, Egypt
      Sohag University Hospital
    Sep 14, 2022

    Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

    Recruiting
    • Olverembatinib
    • +2 more
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital
    Jul 26, 2022

    Chronic Myeloid Leukemia Trial in France (Venetoclax)

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Amiens, France
    • +14 more
    Mar 3, 2023

    Leukemia, Chronic Myelogenous Trial in China (asciminib, best available treatment)

    Recruiting
    • Leukemia, Chronic Myelogenous
    • Chongqing City, Chongqing, China
    • +23 more
    Jan 18, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +4 more
    • Eltrombopag Olamine
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 4, 2022

    Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia
    • Detroit, Michigan
    • +1 more
    May 3, 2022

    B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

    Completed
    • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 25, 2022

    Chronic Myeloid Leukemia in Chronic Phase Trial in Shenzhen (Flumatinib, Dasatinib)

    Recruiting
    • Chronic Myeloid Leukemia in Chronic Phase
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital
    Jul 26, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +36 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jan 23, 2023

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +12 more
    • Tucson, Arizona
      The University of Arizona Cancer Center
    Dec 13, 2022

    New Diagnosed Chronic Phase Chronic Myeloid Leukemia

    Recruiting
    • Validity and Safety
      • Guangzhou, Guangdong, China
        NanfangH
      Apr 9, 2022

      CML, Chronic Phase Trial in Harbin (Flumatinib, Imatinib)

      Not yet recruiting
      • CML, Chronic Phase
      • Harbin, Heilongjiang, China
        Institute of Hematology and Oncology, Harbin The First Hospital
      May 5, 2022

      Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)

      Withdrawn
      • Hematologic Diseases
      • +5 more
      • CliniMACS
      • +7 more
      • Miami, Florida
        Miami Cancer Institute at Baptist Health, Inc.
      Sep 26, 2022

      Among CP-CML Participants Initiating Dasatinib inReal Life

      Completed
      • Chronic Myeloid Leukemia
      • Non-Interventional
      • Paris, France
        Local Institution
      Jun 17, 2022

      Leukemia, Chronic Myelogenous Trial in Japan (Bosutinib)

      Completed
      Has Results
      • Leukemia, Chronic Myelogenous
      • Toyoake-City, Aichi, Japan
      • +20 more
      Apr 26, 2022

      CML, Chronic Phase Trial in Harbin (Flumatinib mesylate tablets (400mg), Flumatinib mesylate tablets (600mg))

      Recruiting
      • CML, Chronic Phase
      • Flumatinib mesylate tablets (400mg)
      • Flumatinib mesylate tablets (600mg)
      • Harbin, Hei Longjiang, China
        Institute of Hematology and Oncology, Harbin The First Hospital
      Apr 28, 2022

      Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)

      Active, not recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Beijing, China
        Peking University People's Hospital(北京大学人民医院)
      Jan 3, 2022

      Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

      Active, not recruiting
      • Acute Myeloid Leukemia
      • +9 more
      • Los Angeles, California
      • +5 more
      Jan 27, 2023

      Generic Imatinib Compared to Glivec® in Real-Life Management of

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Cairo, Egypt
      • +1 more
      Mar 16, 2022

      Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Withdrawal;Drug
      • Imatinib withdrawal
      • +2 more
      • Brno, Czechia
      • +7 more
      Aug 24, 2022